Vimpat® Added as Adjunctive Therapy to One Baseline Antiepileptic Drug

Clinical trial NCT01098162 · COMPLETED

Trial details

NCT number: NCT01098162
Sponsor: UCB Pharma GmbH
Status: COMPLETED
Study type: OBSERVATIONAL

Epilepsies, Partial

Start date: 2010-03-01
Primary completion: 2013-07-01
Enrollment: 576

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.